Molecule Holdings Valuation
| EVRRF Stock | USD 0 0.00 0.00% |
Molecule Holdings seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Molecule Holdings from analyzing the firm fundamentals such as Current Valuation of 5.39 M, return on equity of -10.88, and Profit Margin of (2.43) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Molecule Holdings' price fluctuation is very steady at this time. Calculation of the real value of Molecule Holdings is based on 3 months time horizon. Increasing Molecule Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Molecule pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Molecule Holdings. Since Molecule Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Molecule Pink Sheet. However, Molecule Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0025 | Real 0.0021 | Hype 0.0025 | Naive 0.0025 |
The real value of Molecule Pink Sheet, also known as its intrinsic value, is the underlying worth of Molecule Holdings Company, which is reflected in its stock price. It is based on Molecule Holdings' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Molecule Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Molecule Holdings helps investors to forecast how Molecule pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Molecule Holdings more accurately as focusing exclusively on Molecule Holdings' fundamentals will not take into account other important factors: Molecule Holdings Total Value Analysis
Molecule Holdings is currently projected to have takeover price of 5.39 M with market capitalization of 1.45 M, debt of 817.09 K, and cash on hands of 73.25 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Molecule Holdings fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.39 M | 1.45 M | 817.09 K | 73.25 K |
Molecule Holdings Investor Information
About 17.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.04. Molecule Holdings last dividend was issued on the 17th of September 2020. The entity had 1:10 split on the 17th of September 2020. Based on the key indicators related to Molecule Holdings' liquidity, profitability, solvency, and operating efficiency, Molecule Holdings is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Molecule Holdings Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Molecule Holdings has an asset utilization ratio of 7.64 percent. This implies that the Company is making $0.0764 for each dollar of assets. An increasing asset utilization means that Molecule Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Molecule Holdings Ownership Allocation
Molecule Holdings maintains a total of 97.78 Million outstanding shares. Molecule Holdings secures 16.52 % of its outstanding shares held by insiders and 0.0 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Molecule Holdings Profitability Analysis
The company reported the revenue of 455.26 K. Net Loss for the year was (4.23 M) with loss before overhead, payroll, taxes, and interest of (499.74 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Molecule Holdings' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Molecule Holdings and how it compares across the competition.
About Molecule Holdings Valuation
The pink sheet valuation mechanism determines Molecule Holdings' current worth on a weekly basis. Our valuation model uses a comparative analysis of Molecule Holdings. We calculate exposure to Molecule Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Molecule Holdings's related companies.Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It offers its beverage products under the PHRESH, embody, and CANAJO brands. Molecule Holdings is traded on OTC Exchange in the United States.
8 Steps to conduct Molecule Holdings' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Molecule Holdings' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Molecule Holdings' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Molecule Holdings' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Molecule Holdings' revenue streams: Identify Molecule Holdings' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Molecule Holdings' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Molecule Holdings' growth potential: Evaluate Molecule Holdings' management, business model, and growth potential.
- Determine Molecule Holdings' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Molecule Holdings' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Molecule Holdings Growth Indicators
Investing in growth stocks can be very risky. If the company such as Molecule Holdings does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 95.4 M | |
| Retained Earnings | -8.6 M | |
| Shares Float | 81.8 M |
Complementary Tools for Molecule Pink Sheet analysis
When running Molecule Holdings' price analysis, check to measure Molecule Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecule Holdings is operating at the current time. Most of Molecule Holdings' value examination focuses on studying past and present price action to predict the probability of Molecule Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecule Holdings' price. Additionally, you may evaluate how the addition of Molecule Holdings to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |